Trinean has entered into a global agreement with Bayer CropScience to supply DropSense96 and Xpose droplet readers along with its proprietary cDrop spectral analysis software.
Please read the press release here
Trinean is proud to announce that it has secured a 1 million euro investment in a second closing of its 3.7 million fundraising round. The investment is done by Capricorn Health-tech Fund NV (Leuven, Belgium) which is managed by Capricorn Venture Partners NV.
Trinean announces the release of an updated version of its DropSense96 software modules to DropQuant1.3 and cDrop1.2.
This update allows liquid handling robotics integration of both DropQuant and cDrop in a fully automated set-up using the Trinean API integration software. Furthermore, additional features are included to improve the robustness in data analysis and interpretation.
Trinean announces the expansion of its management team with Yvan Sergeant as Vice-President Commercial Operations.
Please follow this link to the press release
Trinean today announced that it has entered into a license agreement with PerkinElmer to license certain microfluidics technology owned by its subsidiary, Caliper Life Sciences, Inc., in the field of UV/VIS quantification analysis.
Please follow this link to the Press release
Trinean announces the launch of the Xpose, a new benchtop micro-volume spectrophotometer for high speed quantification of 1 to 16 nucleic acid or proteins samples.
This innovative spectrophotometer by Trinean revolutionizes high-speed DNA/RNA/protein quantification by eliminating repetitive loading & cleaning steps on the reader during measuring. Superior accuracy for quantification is reached by UV/VIS spectral subtraction of impurities before quantification using the proprietary algorithms for Spectral Component Profiling.